Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...

Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.

Hindi dapat basta-basta hinahayaan lang ang pagkakaroon ng pangangati sa iyong ari! Alamin dito ang posibleng dahilan at mga ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

Apogee is pitching APG777 as a 'best-in-class' IL-13 inhibitor that could offer robust efficacy and less-frequent dosing than ...

It is a claim that will, undoubtedly, raise eyebrows - or, even more likely, make eyes roll with faint boredom.

LEO Pharma has reported outcomes from the 16-week interim analysis of the Phase IIIb ADHAND trial of tralokinumab for hand atopic dermatitis (AD).

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

The three dollar drugstore product that works better than $300 serums as petroleum jelly is the skincare secret hiding in ...

Are you struggling with dandruff and looking for an anti-dandruff shampoo that truly works? You're not alone. While dandruff ...